Click for best price
Artificial Intelligence Drug Development Market Size, Share 2022
This report contains market size and forecasts of Artificial Intelligence Drug Development in Global, including the following market information:
Global Artificial Intelligence Drug Development Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Artificial Intelligence Drug Development market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Design Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence Drug Development include Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg?Inc. and Numerate, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Intelligence Drug Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence Drug Development Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence Drug Development Market Segment Percentages, by Type, 2021 (%)
Drug Design
Drug Synthesis
Other
Global Artificial Intelligence Drug Development Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence Drug Development Market Segment Percentages, by Application, 2021 (%)
Tumor
Nervous System
Other
Global Artificial Intelligence Drug Development Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Artificial Intelligence Drug Development Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence Drug Development revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Artificial Intelligence Drug Development revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg?Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics
| Report Attributes |
Report Details |
| Report Title |
Artificial Intelligence Drug Development Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence Drug Development Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Intelligence Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence Drug Development Overall Market Size
2.1 Global Artificial Intelligence Drug Development Market Size: 2021 VS 2028
2.2 Global Artificial Intelligence Drug Development Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence Drug Development Players in Global Market
3.2 Top Global Artificial Intelligence Drug Development Companies Ranked by Revenue
3.3 Global Artificial Intelligence Drug Development Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence Drug Development Companies in Global Market, by Revenue in 2021
3.5 Global Companies Artificial Intelligence Drug Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence Drug Development Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence Drug Development Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence Drug Development Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Artificial Intelligence Drug Development Market Size Markets, 2021 & 2028
4.1.2 Drug Design
4.1.3 Drug Synthesis
4.1.4 Other
4.2 By Type - Global Artificial Intelligence Drug Development Revenue & Forecasts
4.2.1 By Type - Global Artificial Intelligence Drug Development Revenue, 2017-2022
4.2.2 By Type - Global Artificial Intelligence Drug Development Revenue, 2023-2028
4.2.3 By Type - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Intelligence Drug Development Market Size, 2021 & 2028
5.1.2 Tumor
5.1.3 Nervous System
5.1.4 Other
5.2 By Application - Global Artificial Intelligence Drug Development Revenue & Forecasts
5.2.1 By Application - Global Artificial Intelligence Drug Development Revenue, 2017-2022
5.2.2 By Application - Global Artificial Intelligence Drug Development Revenue, 2023-2028
5.2.3 By Application - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Artificial Intelligence Drug Development Market Size, 2021 & 2028
6.2 By Region - Global Artificial Intelligence Drug Development Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence Drug Development Revenue, 2017-2022
6.2.2 By Region - Global Artificial Intelligence Drug Development Revenue, 2023-2028
6.2.3 By Region - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Artificial Intelligence Drug Development Revenue, 2017-2028
6.3.2 US Artificial Intelligence Drug Development Market Size, 2017-2028
6.3.3 Canada Artificial Intelligence Drug Development Market Size, 2017-2028
6.3.4 Mexico Artificial Intelligence Drug Development Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence Drug Development Revenue, 2017-2028
6.4.2 Germany Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.3 France Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.4 U.K. Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.5 Italy Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.6 Russia Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.7 Nordic Countries Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.8 Benelux Artificial Intelligence Drug Development Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence Drug Development Revenue, 2017-2028
6.5.2 China Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.3 Japan Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.4 South Korea Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.5 Southeast Asia Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.6 India Artificial Intelligence Drug Development Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Artificial Intelligence Drug Development Revenue, 2017-2028
6.6.2 Brazil Artificial Intelligence Drug Development Market Size, 2017-2028
6.6.3 Argentina Artificial Intelligence Drug Development Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, 2017-2028
6.7.2 Turkey Artificial Intelligence Drug Development Market Size, 2017-2028
6.7.3 Israel Artificial Intelligence Drug Development Market Size, 2017-2028
6.7.4 Saudi Arabia Artificial Intelligence Drug Development Market Size, 2017-2028
6.7.5 UAE Artificial Intelligence Drug Development Market Size, 2017-2028
7 Players Profiles
7.1 Insilico Medicine
7.1.1 Insilico Medicine Corporate Summary
7.1.2 Insilico Medicine Business Overview
7.1.3 Insilico Medicine Artificial Intelligence Drug Development Major Product Offerings
7.1.4 Insilico Medicine Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.1.5 Insilico Medicine Key News
7.2 Cyclica
7.2.1 Cyclica Corporate Summary
7.2.2 Cyclica Business Overview
7.2.3 Cyclica Artificial Intelligence Drug Development Major Product Offerings
7.2.4 Cyclica Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.2.5 Cyclica Key News
7.3 XtalPi Inc.
7.3.1 XtalPi Inc. Corporate Summary
7.3.2 XtalPi Inc. Business Overview
7.3.3 XtalPi Inc. Artificial Intelligence Drug Development Major Product Offerings
7.3.4 XtalPi Inc. Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.3.5 XtalPi Inc. Key News
7.4 Exscientia Limited
7.4.1 Exscientia Limited Corporate Summary
7.4.2 Exscientia Limited Business Overview
7.4.3 Exscientia Limited Artificial Intelligence Drug Development Major Product Offerings
7.4.4 Exscientia Limited Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.4.5 Exscientia Limited Key News
7.5 AiCure, LLC
7.5.1 AiCure, LLC Corporate Summary
7.5.2 AiCure, LLC Business Overview
7.5.3 AiCure, LLC Artificial Intelligence Drug Development Major Product Offerings
7.5.4 AiCure, LLC Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.5.5 AiCure, LLC Key News
7.6 Atomwise
7.6.1 Atomwise Corporate Summary
7.6.2 Atomwise Business Overview
7.6.3 Atomwise Artificial Intelligence Drug Development Major Product Offerings
7.6.4 Atomwise Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.6.5 Atomwise Key News
7.7 Biovista Inc.
7.7.1 Biovista Inc. Corporate Summary
7.7.2 Biovista Inc. Business Overview
7.7.3 Biovista Inc. Artificial Intelligence Drug Development Major Product Offerings
7.7.4 Biovista Inc. Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.7.5 Biovista Inc. Key News
7.8 Breg?Inc.
7.8.1 Breg?Inc. Corporate Summary
7.8.2 Breg?Inc. Business Overview
7.8.3 Breg?Inc. Artificial Intelligence Drug Development Major Product Offerings
7.8.4 Breg?Inc. Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.8.5 Breg?Inc. Key News
7.9 Numerate
7.9.1 Numerate Corporate Summary
7.9.2 Numerate Business Overview
7.9.3 Numerate Artificial Intelligence Drug Development Major Product Offerings
7.9.4 Numerate Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.9.5 Numerate Key News
7.10 Cloud Pharmaceuticals
7.10.1 Cloud Pharmaceuticals Corporate Summary
7.10.2 Cloud Pharmaceuticals Business Overview
7.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Major Product Offerings
7.10.4 Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.10.5 Cloud Pharmaceuticals Key News
7.11 IBM
7.11.1 IBM Corporate Summary
7.11.2 IBM Business Overview
7.11.3 IBM Artificial Intelligence Drug Development Major Product Offerings
7.11.4 IBM Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.11.5 IBM Key News
7.12 NuMedii
7.12.1 NuMedii Corporate Summary
7.12.2 NuMedii Business Overview
7.12.3 NuMedii Artificial Intelligence Drug Development Major Product Offerings
7.12.4 NuMedii Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.12.5 NuMedii Key News
7.13 BenevolentAI
7.13.1 BenevolentAI Corporate Summary
7.13.2 BenevolentAI Business Overview
7.13.3 BenevolentAI Artificial Intelligence Drug Development Major Product Offerings
7.13.4 BenevolentAI Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.13.5 BenevolentAI Key News
7.14 Lam Therapeutics
7.14.1 Lam Therapeutics Corporate Summary
7.14.2 Lam Therapeutics Business Overview
7.14.3 Lam Therapeutics Artificial Intelligence Drug Development Major Product Offerings
7.14.4 Lam Therapeutics Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.14.5 Lam Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Artificial Intelligence Drug Development Market Opportunities & Trends in Global Market
Table 2. Artificial Intelligence Drug Development Market Drivers in Global Market
Table 3. Artificial Intelligence Drug Development Market Restraints in Global Market
Table 4. Key Players of Artificial Intelligence Drug Development in Global Market
Table 5. Top Artificial Intelligence Drug Development Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Artificial Intelligence Drug Development Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Artificial Intelligence Drug Development Revenue Share by Companies, 2017-2022
Table 8. Global Companies Artificial Intelligence Drug Development Product Type
Table 9. List of Global Tier 1 Artificial Intelligence Drug Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Intelligence Drug Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Artificial Intelligence Drug Development Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Artificial Intelligence Drug Development Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Artificial Intelligence Drug Development Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Artificial Intelligence Drug Development Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Artificial Intelligence Drug Development Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Artificial Intelligence Drug Development Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Artificial Intelligence Drug Development Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, (US$, Mn), 2023-2028
Table 30. Insilico Medicine Corporate Summary
Table 31. Insilico Medicine Artificial Intelligence Drug Development Product Offerings
Table 32. Insilico Medicine Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 33. Cyclica Corporate Summary
Table 34. Cyclica Artificial Intelligence Drug Development Product Offerings
Table 35. Cyclica Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 36. XtalPi Inc. Corporate Summary
Table 37. XtalPi Inc. Artificial Intelligence Drug Development Product Offerings
Table 38. XtalPi Inc. Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 39. Exscientia Limited Corporate Summary
Table 40. Exscientia Limited Artificial Intelligence Drug Development Product Offerings
Table 41. Exscientia Limited Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 42. AiCure, LLC Corporate Summary
Table 43. AiCure, LLC Artificial Intelligence Drug Development Product Offerings
Table 44. AiCure, LLC Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 45. Atomwise Corporate Summary
Table 46. Atomwise Artificial Intelligence Drug Development Product Offerings
Table 47. Atomwise Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 48. Biovista Inc. Corporate Summary
Table 49. Biovista Inc. Artificial Intelligence Drug Development Product Offerings
Table 50. Biovista Inc. Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 51. Breg?Inc. Corporate Summary
Table 52. Breg?Inc. Artificial Intelligence Drug Development Product Offerings
Table 53. Breg?Inc. Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 54. Numerate Corporate Summary
Table 55. Numerate Artificial Intelligence Drug Development Product Offerings
Table 56. Numerate Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 57. Cloud Pharmaceuticals Corporate Summary
Table 58. Cloud Pharmaceuticals Artificial Intelligence Drug Development Product Offerings
Table 59. Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 60. IBM Corporate Summary
Table 61. IBM Artificial Intelligence Drug Development Product Offerings
Table 62. IBM Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 63. NuMedii Corporate Summary
Table 64. NuMedii Artificial Intelligence Drug Development Product Offerings
Table 65. NuMedii Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 66. BenevolentAI Corporate Summary
Table 67. BenevolentAI Artificial Intelligence Drug Development Product Offerings
Table 68. BenevolentAI Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
Table 69. Lam Therapeutics Corporate Summary
Table 70. Lam Therapeutics Artificial Intelligence Drug Development Product Offerings
Table 71. Lam Therapeutics Artificial Intelligence Drug Development Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Artificial Intelligence Drug Development Segment by Type in 2021
Figure 2. Artificial Intelligence Drug Development Segment by Application in 2021
Figure 3. Global Artificial Intelligence Drug Development Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Artificial Intelligence Drug Development Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Artificial Intelligence Drug Development Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Artificial Intelligence Drug Development Revenue in 2021
Figure 8. By Type - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 9. By Application - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 10. By Region - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 11. By Country - North America Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 12. US Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 16. Germany Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 17. France Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 24. China Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 28. India Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 30. Brazil Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
Figure 33. Turkey Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Artificial Intelligence Drug Development Revenue, (US$, Mn), 2017-2028
Figure 37. Insilico Medicine Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cyclica Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. XtalPi Inc. Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Exscientia Limited Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AiCure, LLC Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Atomwise Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biovista Inc. Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Breg?Inc. Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Numerate Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. IBM Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. NuMedii Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BenevolentAI Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lam Therapeutics Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
